A Case of Primary Biliary Cirrhosis That Progressed Rapidly after Treatment Involving Rituximab

A Case of Primary Biliary Cirrhosis That Progressed Rapidly after Treatment Involving Rituximab

Primary biliary cirrhosis (PBC) is a progressive liver disease for which limited therapies are recommended. Rituximab, an anti-CD20 monoclonal antibody, is expected to be a useful therapeutic regimen for PBC. Previous studies indicated biochemical and immunological improvement in PBC after rituximab...

Full description

Bibliographic Details
Main Authors: Kazuto Tajiri, Koichi Tsuneyama, Takahiro Miyazono, Kengo Kawai, Masami Minemura, Toshiro Sugiyama
Format: Article
Language:English
Published: Karger Publishers 2013-04-01
Series:Case Reports in Gastroenterology
Subjects:
Primary biliary cirrhosis
Rituximab
Transforming growth factor beta
Online Access:http://www.karger.com/Article/FullText/351173

Internet

http://www.karger.com/Article/FullText/351173

Similar Items